Term
|
Definition
-market name = Sinemet
-must be combined with carbidopa to prevent rapid peripheral decarboxylation and subsequent inabilily to cross blood-brain barrier
-treatment of parkinson’s |
|
|
Term
|
Definition
| often used during a poison emergency |
|
|
Term
|
Definition
| -Strong dopamine D2 receptor antagonist for psychosis that also has strong anticholinergic properties, and hence has a lower probability of causing parkinsonism-like motor side effects |
|
|
Term
|
Definition
-strong dopamine D2 receptor antagonist for psychosis that has a high probability of causing parkinsonism-like motor side effects
-low anticholinergic properties |
|
|
Term
|
Definition
-Atypical antipsychotic that is also a strong antagonist of BOTH serotonin 5-HT2 and dopamine D2 receptors.
-Consequently, this drug causes LESS motor side effects that do “typical” antipsychotics, although it may also increase anxiety/depression |
|
|
Term
|
Definition
-new class of atypical antipsychotic all by itself
-mild presynaptic D2 agonist and a mild postsynaptic D2 antagonist |
|
|
